Its expression rises in both aging and diabetes, and experimental studies have shown that CD38 upregulation under hyperglycemic conditions reduces the NAD+/NADH ratio, promotes mitochondrial dysfunction, and exacerbates renal tubular injury [12,13]. Here, CD38 is linked to diabetes mellitus.